Sydney-headquartered telehealth platform Eucalyptus has recently bagged A$30 million ($22.4 million) in a Series B funding round led by NewView Capital, the Silicon Valley-based investor that also backs digital health firms 23andMe and Hims & Hers. The investing round also saw participation from previous investors Blackbird Ventures and W23, as well as new investor AirTree Ventures.
WHAT IT...
